These effects, together with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two assist the notion of focusing on ACKR3 as a unique method to modulate the opioid process, which could open new therapeutic avenues for opioid-related disorders. Importantly, these receptors were identified https://whyshouldiuseconolidine44210.loginblogin.com/43349664/about-conolidine